Tower Bridge Advisors Sells 366 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Tower Bridge Advisors reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 28,657 shares of the healthcare conglomerate’s stock after selling 366 shares during the quarter. UnitedHealth Group comprises 1.5% of Tower Bridge Advisors’ portfolio, making the stock its 14th biggest holding. Tower Bridge Advisors’ holdings in UnitedHealth Group were worth $14,497,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group in the third quarter worth about $37,000. DecisionPoint Financial LLC grew its stake in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the last quarter. Legacy Investment Solutions LLC bought a new stake in shares of UnitedHealth Group in the third quarter worth about $57,000. Finally, FPC Investment Advisory Inc. grew its stake in shares of UnitedHealth Group by 863.6% in the fourth quarter. FPC Investment Advisory Inc. now owns 106 shares of the healthcare conglomerate’s stock worth $58,000 after purchasing an additional 95 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

Shares of UNH opened at $474.95 on Friday. The firm has a market cap of $437.09 billion, a PE ratio of 30.64, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $516.59 and a two-hundred day simple moving average of $557.16. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $5.83 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.77%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on UNH. Stephens raised their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Oppenheimer raised their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Barclays cut their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $629.32.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.